NASDAQ: BVSBioventus Inc Stock Ownership - Who owns Bioventus?
Insider buying vs selling
Have Bioventus Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Guy P. Nohra | Director | 2025-12-04 | 10,000 | $7.57 | $75.66kSell |
| Michelle McMurryheath | Director | 2025-11-07 | 17,701 | $7.42 | $131.25kSell |
| Mark Leonard Singleton | SVP CFO | 2025-04-11 | 3,875 | $7.57 | $29.33kSell |
| Katrina J. Church | SVP Chief Compliance Officer | 2025-04-11 | 1,283 | $7.57 | $9.71kSell |
| Anthony Dadamio | SVP General Counsel | 2025-04-11 | 2,958 | $7.57 | $22.39kSell |
| Mark Leonard Singleton | SVP CFO | 2025-03-24 | 5,479 | $9.79 | $53.64kSell |
| Katrina J. Church | SVP Chief Compliance Officer | 2025-03-17 | 1,018 | $9.75 | $9.93kSell |
| Anthony Dadamio | SVP General Counsel | 2025-03-17 | 2,615 | $9.75 | $25.50kSell |
| Anthony Dadamio | SVP General Counsel | 2025-02-18 | 4,380 | $10.19 | $44.63kSell |
| Mark Leonard Singleton | SVP CFO | 2025-02-18 | 6,498 | $10.19 | $66.21kSell |
BVS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BVS insiders and whales buy or sell their stock.
BVS Shareholders
What type of owners hold Bioventus Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Smith Nephew PLC | 19.98% | 16,534,814 | $122.03M | Insider |
| Juniper Investment Company LLC | 15.91% | 13,168,697 | $97.18M | Insider |
| Martin P. Sutter | 15.84% | 13,106,565 | $96.73M | Insider |
| Ew Healthcare Partners Acquisition Fund LP | 15.73% | 13,021,324 | $96.10M | Insider |
| Essex Woodlands Management Inc | 15.73% | 13,021,324 | $96.10M | Institution |
| John A. Bartholdson | 8.48% | 7,018,977 | $51.80M | Insider |
| Juniper Investment Company LLC | 8.38% | 6,939,357 | $51.21M | Institution |
| Nantahala Capital Management LLC | 7.02% | 5,810,662 | $42.88M | Institution |
| Spindletop Healthcare Capital LP | 4.72% | 3,906,395 | $28.83M | Insider |
| David J. Parker | 3.93% | 3,255,332 | $24.02M | Insider |
BVS vs Medical Device Stocks
Bioventus Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.